Actinium Pharmaceuticals reported $18K in Debt for its fiscal quarter ending in March of 2025.





Debt Change Date
AbbVie USD 1000K 70.48B Sep/2025
Actinium Pharmaceuticals USD 18K 2K Mar/2025
Amgen USD 54.59B 1.62B Sep/2025
Bioline Rx USD 11.38M 1.22M Sep/2025
Capricor Therapeutics USD 3.38M 0 Mar/2025
Pfizer USD 60.85B 78M Sep/2025